Form D · Pharmaceuticals

Vicept Therapeutics, Inc.

Malvern, PA · CIK 0001469750

Offering snapshot reported Jun 29, 2010 · SEC filing

Reported sold
$15.8M
Offering amount: $15.8M
Investors reported
12
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Aug 4, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.9M$15.8MAug 20, 2009: $6,257,000.00Aug 20, 2009Jun 29, 2010: $15,790,501.00Jun 29, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,257,000 → $15,790,501
  • Reported investors8 → 12

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 29, 2010Amendment$15,790,501$9,533,501vs Aug 20, 200912SEC filing
Aug 20, 2009Initial$6,257,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-133791

Source: Form D, filed Jun 29, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Beck Director
Albert Cha Director
Anand Mehra Director
Christopher Powala Executive
Stephen Tullman Director
Neal Walker Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
101 Lindenwood Drive Suite 130
Malvern, PA, 19355